| Wed, 5 Aug 2026 | Klickstein Lloyd | director, officer: Chief Medical Officer | A-Award | 18,300 | $167.63K |
| Mon, 27 Apr 2026 | Shah Rajeev M. | 10 percent owner | J-Other | 250,000 | — |
| Fri, 20 Feb 2026 | RA Capital Healthcare Fund LP | 10 percent owner | P-Purchase | 74,751 | $543.44K |
| Thu, 19 Feb 2026 | RA Capital Healthcare Fund LP | 10 percent owner | P-Purchase | 74,268 | $535.47K |
| Wed, 18 Feb 2026 | RA Capital Healthcare Fund LP | 10 percent owner | P-Purchase | 74,577 | $525.02K |
| Tue, 7 Apr 2026 | OrbiMed Advisors Israel II Ltd | 10 percent owner | S-Sale | 2,400 | $15.31K |
| Wed, 8 Apr 2026 | OrbiMed Advisors Israel II Ltd | 10 percent owner | S-Sale | 40,416 | $263.51K |
| Wed, 8 Apr 2026 | OrbiMed Advisors Israel II Ltd | 10 percent owner | S-Sale | 32,523 | $204.57K |
| Tue, 7 Apr 2026 | OrbiMed Advisors Israel II Ltd | 10 percent owner | S-Sale | 29,319 | $191.45K |
| Sat, 24 Jan 2026 | Harvey Brian Nicholas | officer: Chief Financial Officer | F-InKind | 546 | $4.61K |
| Sat, 24 Jan 2026 | Schor Chen | director, officer: President & CEO | F-InKind | 1,755 | $14.81K |
| Sat, 24 Jan 2026 | Healey Don | officer: Chief Technology Officer | F-InKind | 535 | $4.52K |
| Sat, 24 Jan 2026 | Aftab Blake | officer: Chief Scientific Officer | F-InKind | 535 | $4.52K |
